OncoDaily Forms Strategic Partnership with the National Foundation for Cancer Research (NFCR)

OncoDaily is thrilled to announce a new strategic partnership with the National Foundation for Cancer Research (NFCR). This collaboration aims to accelerate the dissemination of groundbreaking cancer research and enhance global access to innovative cancer treatments and educational resources. We are committed to driving forward the mission of making significant strides in cancer prevention, early diagnosis, and treatment.

This partnership marks an important step in our shared goal of advancing cancer research and making a tangible impact in the lives of those affected by cancer worldwide.

About OncoDaily

OncoDaily is a leading media platform dedicated to providing the latest news, research updates, and insights in the field of oncology. Our mission is to empower healthcare professionals, researchers, and patients by delivering high-quality, accessible information that drives awareness and knowledge in cancer research and treatment. With a global audience, OncoDaily stands at the forefront of the fight against cancer, offering educational content, podcasts, and expert-led discussions that inform and inspire the oncology community.

About the National Foundation for Cancer Research (NFCR)

The National Foundation for Cancer Research (NFCR) is a 501(c)(3) nonprofit organization co-founded in 1973 by Nobel Laureate Dr. Albert Szent-Györgyi and Attorney/Business Entrepreneur Franklin Salisbury, Sr. NFCR provides scientists in the lab with the critical seed funding they need to make game-changing discoveries in cancer detection, treatments, prevention, and ultimately, a cure for all cancers.

NFCR has distinguished itself in the cancer research sector by emphasizing “high-risk, high-impact” long-term and transformative pioneering research fields often overlooked by other major funding sources. With the support of more than 5.3 million individual donors over the last 50+ years, NFCR has provided more than $415 million in funding to cancer research, prevention, and public education. NFCR-supported research has led to some of the most significant life-saving discoveries that benefit patients today.